Pharmacists take on polypharmacy: can a bundled care model cut costs and improve safety?

This study tests whether a clinical pharmacist-led bundled care model can reduce preventable polypharmacy—the use of unnecessary or potentially harmful multiple medications—in hospitalized adults. Participants are randomly assigned to receive either the pharmacist intervention plus usual care or usual care alone. The trial measures healthcare costs, medication appropriateness, hospital readmissions, and adverse drug events to see if this approach improves patient safety and reduces waste.